Beijing Institute of Ophthalmology, Beijing Tongren Eye Center, Beijing Tongren Hospital, Beijing Ophthalmology & Visual Sciences Key Laboratory, Capital Medical University, Beijing, 100730, China.
Stem Cell Res Ther. 2021 May 1;12(1):259. doi: 10.1186/s13287-021-02345-2.
To report the clinical outcomes of a novel surgical technique, namely simple limbal epithelial transplantation (SLET), for the treatment of limbal stem cell deficiency (LSCD).
Thirteen patients (13 eyes) with LSCD who underwent autologous (10 eyes) or allogeneic (3 eyes) modified SLET between 2018 and 2021 were enrolled in this study. Grades of symblepharon, corneal conjunctivalization, vascularization, opacification, and visual acuity (VA) were evaluated preoperatively and postoperatively. In 2 cases, in vivo confocal microscopy (IVCM) and impression cytology (IC) were performed to assess the proliferation and degeneration of limbal tissue.
At a postoperative follow-up of 6.5±5.3 (range, 2-20) months, 10 (10/13, 76.92%) eyes maintained a successful outcome. The grades of symblepharon, corneal conjunctivalization, vascularization, and opacification were significantly improved after SLET (P<0.05). Two-line improvement in VA was found in 6 (6/10, 60%) eyes of the successful cases. Recurrence of LSCD occurred in 3 (3/13, 23.08%) eyes, and conjunctival cyst occurred in 1 patient. After SLET, the morphology and structure of corneal epithelial cells and epithelial transition around the limbal tissue fragments were detected by IVCM and IC.
Our findings suggest that the SLET is a safe and effective technique for the treatment of LSCD. The corneal stroma and hAM can provide protection and nutrition for the limbal stem cells (LSCs) without negatively influencing the clinical outcomes. IVCM and IC after SLET can evaluate the effectiveness of surgery and the transition of LSCs and corneal epithelial cells.
报告一种新型手术技术,即单纯角膜缘上皮移植术(SLET),治疗角膜缘干细胞缺乏症(LSCD)的临床疗效。
2018 年至 2021 年间,我们对 13 例(13 只眼)LSCD 患者进行了自体(10 只眼)或异体(3 只眼)改良 SLET,评估术前和术后的睑球粘连、角膜结膜化、血管化、混浊和视力(VA)。在 2 例中,进行了活体共聚焦显微镜(IVCM)和印迹细胞学(IC)检查,以评估角膜缘组织的增殖和变性。
术后随访 6.5±5.3(范围 2-20)个月,10 只眼(10/13,76.92%)获得成功。SLET 后,睑球粘连、角膜结膜化、血管化和混浊程度均显著改善(P<0.05)。成功病例中有 6 只眼(6/10,60%)VA 提高两行。3 只眼(3/13,23.08%)复发 LSCD,1 例发生结膜囊肿。SLET 后,通过 IVCM 和 IC 检测到角膜上皮细胞形态和结构以及角膜缘组织碎片周围的上皮移行。
我们的研究结果表明,SLET 是治疗 LSCD 的一种安全有效的技术。角膜基质和 hAM 可为角膜缘干细胞(LSCs)提供保护和营养,而不会对临床疗效产生负面影响。SLET 后 IVCM 和 IC 可评估手术效果以及 LSCs 和角膜上皮细胞的移行。